Literature DB >> 9450225

Infections of the nervous system caused by varicella-zoster virus: a review.

J M Echevarría1, I Casas, P Martínez-Martín.   

Abstract

Varicella-zoster virus (VZV) is a cause of neurologic disease among humans. Both primary infection and recurrence may lead to neurologic infection and disease. Neurologic syndromes associated with acute VZV infection are caused by abnormal immune responses, the most frequent manifestation being cerebellar ataxia. Those associated with recurrences are often due to the direct effect of viral replication in the nervous tissue. VZV reaches the nervous system either through the bloodstream or by direct spread from sensory ganglia where it remains latent. Postherpetic neuralgia, acute encephalitis, aseptic meningitis and myelitis are the most frequent diseases and have been recorded both in association with herpes zoster and in the absence of a cutaneous rash. Early diagnosis may be established by detecting virus-specific DNA sequences in the cerebrospinal fluid (CSF) after amplification by the polymerase chain reaction and then confirmed by detection of intrathecally produced, specific IgG antibody. Virus isolation from CSF and antibody testing in serum are unsuitable for diagnosis. Early acyclovir therapy is recommended in immuno-compromised patients and those with serious disease.

Entities:  

Mesh:

Year:  1997        PMID: 9450225     DOI: 10.1159/000150535

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  14 in total

1.  Hypoglycorrhachia in herpes zoster associated encephalitis of an immunocompetent young male: an unusual presentation.

Authors:  Chun Wing Chan; Kin Ming Tam; Wing Kin To; Tin Chu Law; Wai Keung Kwan
Journal:  J Neurol       Date:  2005-04-04       Impact factor: 4.849

2.  Varicella-zoster meningitis with a late-onset of skin eruption.

Authors:  Anawin Sanguankeo; Sikarin Upala; Suthanya Sornprom; Natanong Thamcharoen
Journal:  BMJ Case Rep       Date:  2015-02-17

3.  Infections of the central nervous system of suspected viral origin: a collaborative study from Finland.

Authors:  M Koskiniemi; T Rantalaiho; H Piiparinen; C H von Bonsdorff; M Färkkilä; A Järvinen; E Kinnunen; S Koskiniemi; L Mannonen; M Muttilainen; K Linnavuori; J Porras; M Puolakkainen; K Räihä; E M Salonen; P Ukkonen; A Vaheri; V Valtonen
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

Review 4.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Antibody to varicella-zoster virus immediate-early protein 62 augments allodynia in zoster via brain-derived neurotrophic factor.

Authors:  Yuka Hama; Kimiyasu Shiraki; Yoshihiro Yoshida; Atsushi Maruyama; Makoto Yasuda; Masaaki Tsuda; Mariko Honda; Michiaki Takahashi; Hiroshi Higuchi; Ichiro Takasaki; Tohru Daikoku; Tadaharu Tsumoto
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

6.  Increased detection rate in diagnosis of herpes simplex virus type 2 meningitis by real-time PCR using cerebrospinal fluid samples.

Authors:  Elisabeth Franzen-Röhl; Annika Tiveljung-Lindell; Lena Grillner; Elisabeth Aurelius
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

7.  Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland.

Authors:  Marjaleena Koskiniemi; Maija Lappalainen; D Scott Schmid; Elena Rubtcova; Vladimir N Loparev
Journal:  Clin Vaccine Immunol       Date:  2007-07-11

8.  Herpes zoster meningoencephalitis: not only a disease of the immunocompromised?

Authors:  A Douglas; P Harris; F Francis; R Norton
Journal:  Infection       Date:  2009-11-10       Impact factor: 7.455

9.  Varicella-zoster meningitis in an immunocompetent young man presenting with a painless erythematous rash.

Authors:  Sahand Imani; Natalie C Palavra; Carly Oboudiyat; Jerome Ip
Journal:  BMJ Case Rep       Date:  2020-01-21

10.  Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease.

Authors:  Stephan W Aberle; Judith H Aberle; Christoph Steininger; Elisabeth Puchhammer-Stöckl
Journal:  Med Microbiol Immunol       Date:  2004-03-02       Impact factor: 4.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.